IQVIA Biotech reposted this
Lovely day at Clinical Outsourcing Group Conference in SF Bay Area with IQVIA Biotech James Kyle Bryan and Melissa Megginson
IQVIA Biotech is a biotech-specialized CRO delivering flexible clinical development solutions for biotech and emerging biopharma companies. Our clinical solutions are built on 25 years of unmatched experience with therapeutically aligned expertise, uniquely designed to deliver full-service solutions on a global scale.
External link for IQVIA Biotech
IQVIA Biotech reposted this
Lovely day at Clinical Outsourcing Group Conference in SF Bay Area with IQVIA Biotech James Kyle Bryan and Melissa Megginson
IQVIA Biotech reposted this
With the ultimate goal of creating accessible, available, and affordable eye health for every child, World Sight Day focuses global attention on the importance of eye care in young people. From reducing screentime to spending more time outdoors, will you pledge to put eye health first? Get involved. https://bit.ly/3zMdlqN #WorldSightDay #LoveYourEyes
Betty Lind, MBA shares her story about how IQVIA Biotech supports employee career growth. “I joined IQVIA Biotech because I was looking for an opportunity to grow as a leader and work with a wider network of clinical research professionals. I discovered that I had more opportunities for growth than I could have ever imagined! In the last two years, I have grown tremendously as a leader, as a professional, and as a team member. I found that I am truly part of an amazing community that deeply cares about how our work impacts the world. I am well supported in my role, artfully challenged, and continuously encouraged to put my skills to good use. I am so thankful to have found a workplace where I truly belong, and where the sky is the limit for growth. I look forward to spending my workdays with my amazing colleagues and making a meaningful impact each and every day.” Join IQVIA Biotech and make a difference with us! https://bit.ly/4hduGK6 #Biotech #CareerProgression #Leadership #Opportunities #Culture #CareerGrowth #Support #Partnership #WeAreIQVIA #MakingaDifference
Platform designs can accelerate development and improve understanding of patient populations, but there are several factors to get right before a master platform can be successful across the full study lifecycle – from defining study operations and infrastructure, to adjusting to dynamic needs. Download our insight brief to learn more. https://bit.ly/487HQUS #oncology #clinicaltrials #earlyphaseoncology
With 200 CAGT clinical trials in the past 5 years and a whole function 100% dedicated to biotech, discover how our experienced CAGT delivery teams can propel you to the forefront of successful CAGT drug development. https://bit.ly/3ZYS0Vu #CAGT #drugdevelopment
World Mental Health Day shines a light on the vital connection between mental health and work. With 60% of the global population working, urgent action is needed to ensure the workplace not only prevents risks to mental health but protects and supports better mental health. Learn how you can get involved. https://bit.ly/4eDTsB9 #WorldMentalHealthDay
IQVIA Biotech reposted this
Unlock the story of President at IQVIA Biotech Megan Hooton's journey spanning over 30 years global operational and R&D experience in our latest 12 Questions With https://lnkd.in/e9WrNfkk
Endpoints in malignant hematology studies differ significantly from those used for solid tumors. In this white paper, Christopher Morley and Sari Heitner Enschede, MD consider the most effective investigational agents for blood-based cancers. Download now. https://bit.ly/3U3HKrp #oncology #hematology #biotech #ClinicalTrials #diversity
Artificial Intelligence (AI) is revolutionizing clinical operations and enhancing indication prioritization – but biotech companies need to know how to leverage AI if they’re to thrive in the current market. To understand how, watch our latest on-demand webinar with IQVIA Biotech’s Megan Hooton, IQVIA Institute's Murray Aitken and IQVIA's Keith McDonald. https://bit.ly/484IjXF #AI #clinicaloperations
Developing successful central nervous system (CNS) drugs is a complex process. But with more than 1,000 CNS clinical trials in the past 10 years, and board-certified neurologists on staff, IQVIA Biotech understands the complexities at every step and across a wide range of indications. Learn more. https://bit.ly/4dGGnFU #CNS